New webinar series helps researchers get results from data
This week Lifebit is launching a new genomics webinar series for researchers to learn how Lifebit’s solutions can transform research, accelerate results […]
What’s limiting AI in transforming research and drug discovery? And how can we solve these problems?
Introduction to health data, drug discovery and AI Efforts to address AI challenges in research and drug discovery are paramount for advancing […]
Leveraging AI for target validation in drug discovery
Introduction to health data, drug discovery and AI Healthcare is one of the most data-rich industries and the creation of large datasets […]
The four key requirements of patient registry software
Introduction to patient registry software Understanding patient registry software requirements is critical for effective implementation. Meeting patient registry software requirements ensures that […]
Challenges facing patient registries in the US
Introduction to patient registries Patient registries are databases that collect and store information about patients with a particular disease or condition. Research […]
What are patient registries, and why are they important?
Introduction to patient registries Understanding and treating disease is a data problem, with research indicating that a tenfold increase in dataset size […]
Future for drug development lies in Drug Discovery 2.0
LONDON, UK – 1pm, 12 October 2023: Exploring the future of drug development through innovative technologies. This month, Lifebit has unveiled Drug […]
The ultimate application of precision medicine? The role of secure data federation in newborn genomic screening for rare diseases
LONDON, UK – 1pm, 11 October 2023 Published this week in the Rare Disease and Orphan Drugs Journal, a new scientific review by […]
What are the current challenges of drug discovery?
Introduction – drug development requires time and money New drugs must meet very high efficacy and safety standards in large, randomized controlled clinical trials […]
Drug discovery 2.0 – revolutionizing the quest for innovative drugs through data-driven insights
Introduction Worldwide the pharmaceutical industry is in crisis. Reliant on wet labs, the industry is stuck in ‘drug discovery 1.0’ – slow, expensive and […]
Closing the gap in health data diversity to benefit patients and produce global insights
Introduction to Data Diversity In 2003, the Human Genome Project identified that 99.9% of human DNA is identical between individuals. This enabled researchers […]
Targeting cancer through large-scale data analysis
Introduction to World Cancer Research Day September 24th, World Cancer Research Day, is a global international movement dedicated to maintaining the momentum […]